Related Experiment Video
Updated: Nov 2, 2025

Preparation and Maintenance of Bioexclusion IsoPositive Cage Experiment for Human Fecal Transplantation into Germ-Free Mice
Published on: February 28, 2025
Consistent Alterations of Human Fecal Microbes After Transplantation into Germ-free Mice
Yanze Li1, Wenming Cao1, Na L Gao1
1MOE Key Laboratory of Molecular Biophysics, Hubei Key Laboratory of Bioinformatics and Molecular-imaging, Department of Bioinformatics and Systems Biology, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan 430074, China.
Abstract:
Fecal microbiota transplantation (FMT) of human fecal samples into germ-free (GF) mice is useful for establishing causal relationships between the gut microbiota and human phenotypes. However, due to the intrinsic differences between human and mouse intestines and the different diets of the two organisms, it may not be possible to replicate human phenotypes in mice through FMT; similarly, treatments that are effective in mouse models may not be effective in humans. In this study, we aimed to identify human gut microbes that undergo significant and consistent changes (i.e., in relative abundances) after transplantation into GF mice in multiple experimental settings. We collected 16S rDNA-seq data from four published studies and analyzed the gut microbiota profiles from 1713 human-mouse pairs. Strikingly, on average, we found that only 47% of the human gut microbes could be re-established in mice at the species level, among which more than 1/3 underwent significant changes (referred to as "variable taxa"). Most of the human gut microbes that underwent significant changes were consistent across multiple human-mouse pairs and experimental settings. Consequently, about 1/3 of human samples changed their enterotypes, i.e., significant changes in their leading species after FMT. Mice fed with a controlled diet showed a lower enterotype change rate (23.5%) than those fed with a noncontrolled diet (49.0%), suggesting a possible solution for rescue. Most of the variable taxa have been reported to be implicated in human diseases, with some recognized as the causative species. Our results highlight the challenges of using a mouse model to replicate human gut microbiota-associated phenotypes, provide useful information for researchers using mice in gut microbiota studies, and call for additional validations after FMT. An online database named FMT-DB is publicly available at http://fmt2mice.humangut.info/#/.
Insights
Fecal microbiota transplantation (FMT) into mice re-establishes only 47% of human gut microbes, with many changing significantly. Controlled diets may improve microbial stability in mouse models for gut health research.
Area of Science:
- Microbiology
- Gastroenterology
- Animal Models
Background:
- Fecal microbiota transplantation (FMT) into germ-free (GF) mice models human gut microbiota.
- Differences in intestinal environments and diets limit direct translation of mouse model findings to humans.
Purpose of the Study:
- To identify human gut microbes with consistent abundance changes after FMT into GF mice.
- To assess the reliability of mouse models for human gut microbiota research.
Main Methods:
- Analysis of 16S rDNA sequencing data from 1713 human-mouse FMT pairs across four studies.
- Comparison of microbial community structures and enterotype stability between human and mouse gut environments.
Main Results:
- On average, only 47% of human gut microbes were re-established at the species level in mice.
- Over one-third of re-established microbes showed significant, consistent abundance changes ('variable taxa').
- Approximately 33% of human samples shifted enterotypes post-FMT, with controlled diets reducing this rate to 23.5%.
Conclusions:
- Significant microbial variability and enterotype shifts challenge the direct replication of human gut phenotypes in mice.
- Controlled diets may enhance the stability of transplanted human microbiota in mouse models.
- Further validation is crucial when extrapolating FMT mouse model findings to human health and disease.

